⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JUNS News
Jupiter Neurosciences, Inc. Common Stock
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
globenewswire.com
JUNS
Form 8-K
sec.gov
JUNS
Form 8-K
sec.gov
JUNS
Form 8-K
sec.gov
JUNS
Form 8-K
sec.gov
JUNS
Form 8-K
sec.gov
JUNS
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
globenewswire.com
JUNS
PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
globenewswire.com
JUNS
Form 8-K
sec.gov
JUNS
Jupiter Neurosciences, Inc. Announces Reverse Stock Split
globenewswire.com
JUNS